Aspire Medical Innovation was founded in Munich, Germany in 2015 by a team of dedicated med-tec professionals working together for almost two decades. Aspire’s main focus is to enhance medical benefit, innovation and growth mainly in the emerging regenerative medicine sector by supporting their clients in the development and marketing of novel therapeutic options and medical device systems. The Aspire team has developed, represented and positioned a number of products from disposable delivery devices for use during surgery, to point of care systems that enable in vivo treatment in the private practice. With the Marrow Cellution™ Autologous Bone Marrow Aspiration & Bone Graft Harvesting System Aspire brings the new Gold Standard for cancellous liquid and solid bone graft retrieval to the European market place.